3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Waldenstrom Macroglobulinemia
1
Neoplasm, Residual
1
Interventions
blinatumomab
16
Cyclophosphamide
15
fludarabine phosphate
8
fludarabine
8
Methotrexate
7
Cytarabine
7
Rituximab
6
Vincristine
5
Mercaptopurine
5
Melphalan
4
Daunorubicin
4
obinutuzumab
3
Whole-Body Irradiation
3
Immunotherapy, Adoptive
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
Doxorubicin
3
Dexamethasone
3
Asparaginase
3
tisagenlecleucel
2
thymoglobulin
2
pegaspargase
2
Vindesine
2
Thioguanine
2
Teniposide
2
Stem Cell Transplantation
2
Radiotherapy
2
Prednisone
2
Prednisolone
2
N,N-dicyclohexyl-isoborneol-10-sulfonamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Clonal Evolution
×
Lymphoid
×
Clear all
NCT03521596
2025-11-18
FIL_BIOWM
Fondazione Italiana Linfomi - ETS
Completed
300 enrolled